Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00

АШУҮИС — Судалгааны мэдээлэл (CRIS)

Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001

Browse

Search Results

Now showing 1 - 4 of 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Global multi-societies endorsement of the MAFLD definition
    (2024)
    Alboraie, Mohamed
    ;
    Tanwandee, Tawesak
    ;
    Xu, Xiaoyuan
    ;
    Nikolova, Dafina
    ;
    Estupiñan, Enrique Carrera
    Scopus© Citations 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.
    (2025-02)
    Choudhury, Ashok
    ;
    Kulkarni, Anand V
    ;
    Arora, Vinod
    ;
    Soin, A S
    ;
    Dokmeci, Abdul Kadir
    Scopus© Citations 103
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
    (2025-04)
    Eslam, Mohammed
    ;
    Fan, Jian-Gao
    ;
    Yu, Ming-Lung
    ;
    Wong, Vincent Wai-Sun
    ;
    Cua, Ian Homer
    Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.
    Scopus© Citations 210
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
    (The Korean Association for the Study of the Liver, 2017-06) ;
    Lee, Hye Won
    ;
    George, Jacob
    ;
    Munkh-Orshikh, Dashchirev
    ;
    Enkhtuvshin, Baasankhuu
    BACKGROUND/AIMS: Mongolia has one of the highest hepatitis A, C, B and D infection incidences worldwide. We sought to investigate changes in the proportion of acute viral hepatitis types in Mongolia over the last decade. METHODS: The cohort comprised 546 consecutive patients clinically diagnosed with acute viral hepatitis from January 2012 to December 2014 in Ulaanbaatar Hospital, Mongolia. A time trend analysis investigating the change in proportion of acute hepatitis A virus, hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis delta virus (HDV) infection among the cohort with respect to a previous published study was undertaken. RESULTS: Acute hepatitis A, B and C was diagnosed in 50.9%, 26.2% and 6.0% of the cohort. Notably, 16.8% of the cohort had a dual infection. The etiologies of acute viral hepatitis were varied by age groups. The most common cause of acute viral hepatitis among 2-19 year olds was hepatitis A, HBV and superinfection with HDV among 20-40 year olds, and HCV among 40-49 year olds. Patients with more than one hepatitis virus infection were significantly older, more likely to be male and had a higher prevalence of all risk factors for disease acquisition. These patients also had more severe liver disease at presentation compared to those with mono-infection. CONCLUSIONS: Acute viral hepatitis is still prevalent in Mongolia. Thus, the need for proper infection control is increasing in this country.
    Scopus© Citations 15